LONDON (dpa-AFX) - The British investment bank Barclays has left its rating for Schott Pharma at "Equal Weight" with a target price of 30 euros after the figures for the first quarter. The Mainz-based company's sales and operating result (EBITDA) exceeded its forecasts and consensus estimates, analyst Gaurav Jain wrote in an initial reaction available on Thursday./edh/tih

Publication of the original study: 29.02.2024 / 07:02 / GMT

First release of the original study: 29.02.2024 / 07:07 / GMT

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------